Zika Virus Vaccines

The Live-Attenuated vaccine is produced to the disease caused by Zika Virus. The monovalent form of the antibody is outlined against Zika infection contamination. Zika Virus has a place with the Genus Flavivirus, or, in other words the Aedes mosquitos. The comprehension of flavivirus molecule structure, meaning of E dimers as the key antigenic target, and profound comprehension of balance systems help to build up the antibody.

  • Zika Virus Vaccines Clinical Trials
  • Zika Virus Vaccine Development
  • Zika Virus Vaccines Recent Research
  • Zika Virus Vaccines Recent Research
  • Purified Inactivated Vaccine

Related Conference of Zika Virus Vaccines

February 15-16, 2021

14th International Conference on Biofuels and Bioenergy

Paris, France
March 26-27, 2021

10th World Conference on Earth & Environmental Science

Edinburgh, Scotland
April 06-07, 2021

9th World Climate Congress & Expo

Bangkok, Thailand
July 28-29, 2021

9th World Congress and Expo on Green Energy

London, UK
July 28-29, 2021

13th World Congress and Expo on Recycling

London, UK
September 13-14, 2021

19th Global Recycling Expo

London, UK
September 13-14, 2021

12th World Climate Change Conference

London, UK
September 21-22, 2021

9th World Climate Change Congress

Kyoto, Japan
September 24-25, 2021

10th Environmental Science and Pollution Control

Tokyo, Japan
October 18-19, 2021

10th World Conference on Climate Change

Rome, Italy

Zika Virus Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in